Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiers. [electronic resource] by
- Maoleekoonpairoj, S
- Mittelman, A
- Savona, S
- Ahmed, T
- Puccio, C
- Gafney, E
- Skelos, A
- Arnold, P
- Coombe, N
- Baskind, P
Producer: 19900109
In:
Journal of clinical microbiology vol. 27
Availability: No items available.
|
|
5.
|
A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma. [electronic resource] by
- Mittelman, A
- Huberman, M
- Puccio, C
- Fallon, B
- Tessitore, J
- Savona, S
- Eyre, R
- Gafney, E
- Wick, M
- Skelos, A
Producer: 19900927
In:
Cancer vol. 66
Availability: No items available.
|
|
6.
|
|
|
7.
|
Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2. [electronic resource] by
- Mittelman, A
- Savona, S
- Gafney, E
- Penichet, K O
- Lin, B Y
- Levitt, D
- Ahmed, T
- Arlin, Z A
- Baskind, P
- Needleman, D
Producer: 19891120
In:
Journal of biological response modifiers vol. 8
Availability: No items available.
|